$41.00
Manufacturer: Germany
Purpose: Zocardis 30 inhibits ACE, treats hypertension, heart failure, and myocardial infarction.
Description
Zocardis 30 (Zofenopril Calcium) Coated Tablets 30 mg. №28
Ingredients
Active ingredient: Zofenopril calcium 30 mg.
Dosage
Dosage: The usual dose is 30 mg once daily. It is important to follow the instructions of your healthcare provider.
Indications
Indications: Zocardis 30 is indicated for the treatment of hypertension and congestive heart failure.
Contraindications
Contraindications: Do not use Zocardis 30 if you are allergic to zofenopril or any other ACE inhibitors.
Directions
Directions: Swallow the tablet whole with a glass of water. It can be taken with or without food.
Scientific Evidence
Zofenopril, the active ingredient in Zocardis 30, is an ACE inhibitor with proven efficacy in the treatment of hypertension and heart failure. Studies have shown that zofenopril effectively lowers blood pressure and improves cardiac function in patients with heart failure. Research published in the European Heart Journal demonstrated the benefits of zofenopril in reducing cardiovascular events and mortality rates in high-risk patients.
Additional Information
Zocardis 30 is well-tolerated with a favorable safety profile. Common side effects may include dizziness, cough, and fatigue. It is important to inform your healthcare provider of any existing medical conditions or medications before starting Zocardis 30 therapy.
Pharmacological Effects: Zofenopril works by inhibiting the angiotensin-converting enzyme, leading to vasodilation and reduced aldosterone secretion. This mechanism helps to lower blood pressure and improve cardiac function.
Clinical Trials: Clinical trials have shown that zofenopril is as effective as other ACE inhibitors in the management of hypertension and heart failure. A study published in the Journal of Hypertension compared the efficacy of zofenopril with enalapril and found similar outcomes in blood pressure control and cardiovascular risk reduction.
Recent Reviews